Circular RNA Circ_HECTD1 Regulates Cell Injury After Cerebral Infarction by MiR-27a-3p/FSTL1 Axis
Overview
Authors
Affiliations
Cerebral infarction is a common cerebrovascular disease caused by neural cell injury, with high mortality worldwide. Circular RNAs HECT domain E3 ubiquitin-protein ligase 1 (circ_HECTD1) has been reported to be related to the oxygen-glucose deprivation/reperfusion (OGD/R)-caused neuronal damage in cerebral ischemia. This study is designed to explore the role and mechanism of circ_HECTD1 in OGD/R-induced cell injury in cerebral ischemia. Circ_HECTD1, microRNA-27a-3p (miR-27a-3p), and Follistatin-like 1 (FSTL1) level were detected by real-time quantitative polymerase chain reaction (RT-qPCR). The localization of circ_HECTD1 was analyzed by subcellular fractionation assay. Cell proliferative ability and apoptosis were assessed by 5-ethynyl-2'-deoxyuridine (EdU), 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide (MTT), and flow cytometry assays. The protein levels of proliferating cell nuclear antigen (PCNA), B-cell lymphoma-2 (Bcl-2), Bcl-2 related X protein (Bax), Cleaved poly-ADP-ribose polymerase (PARP), and FSTL1 were examined by western blot assay. The binding relationship between miR-27a-3p and circ_HECTD1 or FSTL1 was predicted by starbase 3.0 then verified by a dual-luciferase reporter assay. Circ_HECTD1 and FSTL1 were highly expressed, and miR-27a-3p was decreased in OGD/R-treated HT22 cells. Moreover, circ_HECTD1 knockdown could boost cell proliferative ability and repress apoptosis in OGD/R-triggered HT22 cells . Mechanical analysis discovered that circ_HECTD1 could regulate FSTL1 expression by sponging miR-27a-3p. Circ_HECTD1 deficiency could mitigate OGD/R-induced HT22 cell damage by modulating the miR-27a-3p/FSTL1 axis, providing a promising therapeutic target for cerebral infarction treatment.
Long noncoding RNA H19 knockdown promotes angiogenesis via IMP2 after ischemic stroke.
Zhong L, Fan J, Yan F, Yang Z, Hu Y, Li L CNS Neurosci Ther. 2024; 30(8):e70000.
PMID: 39161158 PMC: 11333717. DOI: 10.1111/cns.70000.
Crosstalk between ubiquitin ligases and ncRNAs drives cardiovascular disease progression.
You J, Wen Z, Tian J, Lv X, Li R, Li S Front Immunol. 2024; 15:1335519.
PMID: 38515760 PMC: 10954775. DOI: 10.3389/fimmu.2024.1335519.
Circular RNAs: Promising Treatment Targets and Biomarkers of Ischemic Stroke.
Xu G, Liu G, Wang Z, Li Y, Fang W Int J Mol Sci. 2024; 25(1).
PMID: 38203348 PMC: 10779226. DOI: 10.3390/ijms25010178.
CircRNA and Stroke: New Insight of Potential Biomarkers and Therapeutic Targets.
Chen X, Tan Q, Chen K, Zheng D, Deng H, He S Neurochem Res. 2023; 49(3):557-567.
PMID: 38063946 DOI: 10.1007/s11064-023-04077-6.
Jiang M, Wang X, Jiang S Mol Med Rep. 2023; 28(5).
PMID: 37772397 PMC: 10568247. DOI: 10.3892/mmr.2023.13107.